AstraZeneca PLC - ESG Rating & Company Profile powered by AI
The page contains a zero-cost Sustainability analysis covering AstraZeneca PLC. If you work at AstraZeneca PLC and you wish to licence your Sustainability aseessment, please get in touch. This page contains a Q&A section for AstraZeneca PLC.
AstraZeneca PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.3; made up of an environmental score of 4.0, social score of 5.0 and governance score of 6.9.
5.3
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 645 | Biomm SA | 5.4 | High |
| 645 | Tiziana Life Sciences PLC | 5.4 | High |
| 658 | AstraZeneca PLC | 5.3 | High |
| 658 | Cellmid Ltd | 5.3 | High |
| 658 | Bio-Techne Corp | 5.3 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does AstraZeneca PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes AstraZeneca PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes AstraZeneca PLC report the average age of the workforce?
Sign up for free to unlockDoes AstraZeneca PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes AstraZeneca PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes AstraZeneca PLC disclose cybersecurity risks?
Sign up for free to unlockDoes AstraZeneca PLC offer flexible work?
Sign up for free to unlockDoes AstraZeneca PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes AstraZeneca PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes AstraZeneca PLC conduct supply chain audits?
Sign up for free to unlockDoes AstraZeneca PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes AstraZeneca PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes AstraZeneca PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes AstraZeneca PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes AstraZeneca PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes AstraZeneca PLC disclose water use targets?
Sign up for free to unlockDoes AstraZeneca PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid AstraZeneca PLC have a product recall in the last two years?
Sign up for free to unlockDoes AstraZeneca PLC disclose incidents of discrimination?
Sign up for free to unlockDoes AstraZeneca PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas AstraZeneca PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes AstraZeneca PLC disclose parental leave metrics?
Sign up for free to unlockDoes AstraZeneca PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes AstraZeneca PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes AstraZeneca PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes AstraZeneca PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes AstraZeneca PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes AstraZeneca PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs AstraZeneca PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes AstraZeneca PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes AstraZeneca PLC disclose its waste policy?
Sign up for free to unlockDoes AstraZeneca PLC report according to TCFD requirements?
Sign up for free to unlockDoes AstraZeneca PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes AstraZeneca PLC disclose energy use targets?
Sign up for free to unlockDoes AstraZeneca PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes AstraZeneca PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for AstraZeneca PLC
These potential risks are based on the size, segment and geographies of the company.
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. The company's marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; Seroquel IR/Seroquel XR for schizophrenia bipolar disease; Nexium, and Losec/Prilosec for gastroenterology; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.